Cargando…
Personalized medicine for patients with COPD: where are we?
Chronic airflow limitation is the common denominator of patients with chronic obstructive pulmonary disease (COPD). However, it is not possible to predict morbidity and mortality of individual patients based on the degree of lung function impairment, nor does the degree of airflow limitation allow g...
Autores principales: | Franssen, Frits ME, Alter, Peter, Bar, Nadav, Benedikter, Birke J, Iurato, Stella, Maier, Dieter, Maxheim, Michael, Roessler, Fabienne K, Spruit, Martijn A, Vogelmeier, Claus F, Wouters, Emiel FM, Schmeck, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636434/ https://www.ncbi.nlm.nih.gov/pubmed/31371934 http://dx.doi.org/10.2147/COPD.S175706 |
Ejemplares similares
-
Novel computational analysis of large transcriptome datasets identifies sets of genes distinguishing chronic obstructive pulmonary disease from healthy lung samples
por: Roessler, Fabienne K., et al.
Publicado: (2021) -
Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
por: Franssen, Frits ME, et al.
Publicado: (2011) -
COPD and exercise: does it make a difference?
por: Spruit, Martijn A., et al.
Publicado: (2016) -
Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study
por: Wilke, Sarah, et al.
Publicado: (2012) -
Metabolic load during strength training or NMES in individuals with COPD: results from the DICES trial
por: Sillen, Maurice JH, et al.
Publicado: (2014)